What are the MUSA (Morphological Uterus Sonographic Assessment) criteria for diagnosing adenomyosis in a premenopausal woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MUSA Criteria for Adenomyosis

The MUSA (Morphological Uterus Sonographic Assessment) criteria are standardized sonographic features divided into direct signs (indicating ectopic endometrial tissue in myometrium) and indirect signs (reflecting secondary myometrial changes) used to diagnose adenomyosis on transvaginal ultrasound. 1

Direct Features of Adenomyosis

These features indicate the presence of ectopic endometrial tissue within the myometrium:

  • Myometrial cysts: Small anechoic or hypoechoic round areas within the myometrium, representing dilated endometrial glands containing fluid 1, 2

  • Hyperechogenic islands: Echogenic nodular areas within the myometrium representing ectopic endometrial glands and stroma 1, 3

  • Echogenic subendometrial lines and buds: Linear or nodular echogenic structures radiating from the endometrium into the myometrium, representing ectopic glands extending from the endometrial-myometrial junction 1, 3

Indirect Features of Adenomyosis

These features reflect secondary changes in the myometrium due to the presence of adenomyosis:

  • Globular uterus: Diffuse uterine enlargement with a rounded configuration rather than the normal pear shape 1, 3

  • Asymmetrical myometrial thickening: Unequal thickness of the anterior and posterior myometrial walls, with one wall significantly thicker than the other 1, 2

  • Fan-shaped shadowing: Thin "venetian blind" acoustic shadows extending from the myometrium, caused by muscular hyperplasia and hypertrophy 1, 3

  • Translesional vascularity: Penetrating vessels coursing through affected myometrium on color Doppler imaging, reflecting increased uterine vascularity 1, 3

  • Irregular junctional zone: Loss of the normal smooth interface between endometrium and myometrium, with blurring or irregularity of this border 1, 2

  • Interrupted junctional zone: Focal breaks or discontinuity in the junctional zone 1

Diagnostic Approach

  • Perform transvaginal ultrasound during the early proliferative phase (days 4-6) of the menstrual cycle when the endometrium is thinnest, allowing optimal visualization of myometrial features and the junctional zone 4

  • Use three-dimensional (3D) ultrasound when available to optimize visualization of the junctional zone and assess the full extent of disease 1

  • Combine both transabdominal and transvaginal approaches to fully assess pelvic structures and ensure adequate visualization of the endometrium and myometrium 4

  • Obtain cine clips and coronal reformatted images to survey the entire endometrial-myometrial border comprehensively 3

Diagnostic Performance

  • Transvaginal ultrasound using MUSA criteria demonstrates pooled sensitivity of 82.5% and specificity of 84.6% for adenomyosis diagnosis, making it the first-line imaging modality 4

  • Diagnosis requires at least one direct sonographic feature to confirm the presence of adenomyosis 5

  • Sensitivity drops significantly (from 97.8% to 33.3%) when coexisting fibroids are present, as leiomyomas can obscure adenomyotic features 4

Critical Pitfalls to Avoid

  • Do not accept imaging performed during the secretory phase or menstruation as optimal for adenomyosis diagnosis, since endometrial thickening during these phases obscures myometrial detail 4

  • Approximately 16% of symptomatic patients may not demonstrate direct ultrasound signs despite clinical adenomyosis, requiring integration of clinical context with imaging findings 4

  • Standard pelvic ultrasound protocols do not routinely include the detailed assessment needed to identify adenomyosis features, so specifically evaluate for MUSA criteria 4

  • Consider MRI when ultrasound is inconclusive or when adenomyosis obscures endometrial visualization, as MRI demonstrates 78-88% sensitivity and 67-93% specificity 4

Distinguishing Adenomyosis from Mimics

  • Leiomyomas typically appear as well-defined masses with peripheral vascularity, unlike the diffuse heterogeneous appearance of adenomyosis 3

  • Uterine contractions are transient and resolve on repeat imaging, whereas adenomyotic features persist 3

  • Heterogeneous myometrium with blurring of the endometrial border is the hallmark combination that results from the presence of ectopic glands and muscular hyperplasia in adenomyosis 3, 6

References

Research

Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2022

Research

Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2015

Research

Adenomyosis: A Sonographic Diagnosis.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2018

Guideline

Optimal Timing for Adenomyosis Diagnosis on Scan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Grading Sonographic Severity of Adenomyosis: A Pilot Study Assessing Feasibility and Interobserver Reliability.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2025

Related Questions

What does minimal heterogeneity of the myometrium (middle layer of the uterine wall) mean?
What are the causes of an enlarged uterus?
What are the diagnostic criteria and imaging modalities for uterine adenomyosis on Ultrasound (USG)?
How do you score adenomyosis?
At what weeks does the uterus become palpable per abdomen (via abdominal examination)?
What antibiotics should be given to a patient with a complex fistula-in-ano and signs of infection, such as increased drainage, redness, or fever?
What are the risks and considerations for a patient taking atenolol (beta-blocker) and carvedilol (beta-blocker) together, particularly with a history of cardiovascular disease, including heart failure, hypertension, or coronary artery disease?
Is it safe to start azithromycin therapy in a patient with tachycardia and elevated troponin levels who is currently taking vortioxetine, carbamazepine, quetiapine, and duloxetine?
What are the recommendations for using Electrical Impedance Tomography (EIT) monitoring in critically ill patients with severe lung disease or acute respiratory distress syndrome?
What is the recommended management for a patient with a confirmed intracardiac thrombus, particularly those with a history of atrial fibrillation or recent myocardial infarction, to prevent further complications?
What is Electrical Impedance Tomography (EIT) monitoring, how does it work, and what are its uses in critically ill adult patients with severe lung disease or Acute Respiratory Distress Syndrome (ARDS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.